Natco Pharma : Q1FY18 Results
DSIJ Intelligence / 07 Aug 2017
Natco Pharma reported its results for the quarter ended June 30, 2017 on Monday. The company's total sales for Q1FY18 came in at Rs 445.3 crore, which represent a 22.9 per cent sequential decline and 30.9 per cent YoY increase.
Natco Pharma reported its results for the quarter ended June 30, 2017 on Monday.
The company's total sales for Q1FY18 came in at Rs 445.3 crore, which represent a 22.9 per cent sequential decline and 30.9 per cent YoY increase.
Its operating profit (EBIT) for the quarter was Rs 121.7 crore and its EBIT margin stood at 27.3 per cent.
The company's PAT was Rs 93.7 crore, which represents a sequential QoQ decline of 46.9 per cent and a YoY increase of 97.3 per cent.
The company's board of directors has recommended payment of an interim dividend of Rs 1.25 (i.e. 62.5 per cent) per equity share of Rs 2 each for FY2017-18. The company has fixed August 18, 2017 as the record date for the purpose of payment of interim dividend. The interim dividend pay-by-date is August 23, 2017.
Natco Pharma is engaged in developing, manufacturing and marketing finished dosage formulations (FDF) and active pharmaceutical ingredients (APIs).
If you want to stay updated with the share market news today, keep a close watch on the indian stock market today with real time movements like sensex today live and overall stock market today trends. Investors tracking ipo allotment status, ipo news today, or the latest ipo india can also follow daily updates along with bse share price live data. Whether you are learning how to invest in stock market in india, preparing for a market crash today, or searching for the best stocks to buy in india, insights on top gainers today india, top losers today india, trending stocks india and long term stocks india help in making informed investment decisions.